Researcher.Life Logo

Nuclear Medicine Communications : Impact Factor & More

eISSN: 1473-5628pISSN: 0143-3636

Key Metrics

CiteScore
3.1
Impact Factor
< 5
SJR
Q3Radiology, Nuclear Medicine and Imaging
SNIP
0.59
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Nuclear Medicine Communications

Nuclear Medicine Communications Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1980
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Nuclear Medicine Communications ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Nuclear Medicine Communications

Impact of PET/computed tomography image reconstruction methods on Hopkins score in therapy response assessment of head and neck cancer patients.
  • 1 Jun 2026
  • Nuclear medicine communications
Role of [ 18 F]fluorodeoxyglucose positron emission tomography-computed tomography metabolic radiomics in predicting response to chemotherapy in patients with non-small cell lung cancer.
  • 1 Jun 2026
  • Nuclear medicine communications
Prediction of programmed death-ligand 1 expression levels in non-small cell lung cancer patients based on 18 F-fluorodeoxyglucose PET/computed tomography radiomics features.
  • 1 Jun 2026
  • Nuclear medicine communications
Impact of acquisition timing and background uptake on [131I]meta-iodobenzylguanidine SPECT/CT interpretation in pheochromocytoma and adrenal adenoma: Erratum.
  • 1 Jun 2026
  • Nuclear medicine communications
Breaking the shackles of morphology: a novel perspective on immunotherapy evaluation for nasopharyngeal carcinoma using multimodal imaging and radiomics - a review.
  • 1 Jun 2026
  • Nuclear medicine communications
Predicting persistent/recurrent cervical lymph node metastasis in papillary thyroid carcinoma with PET/CT-based multimodal radiomics: an image-pathology matching study.
  • 1 Jun 2026
  • Nuclear medicine communications
Impact of PET/computed tomography image reconstruction methods on Hopkins score in therapy response assessment of head and neck cancer patients.
  • 1 Jun 2026
  • Nuclear medicine communications
Role of [ 18 F]fluorodeoxyglucose positron emission tomography-computed tomography metabolic radiomics in predicting response to chemotherapy in patients with non-small cell lung cancer.
  • 1 Jun 2026
  • Nuclear medicine communications
Prediction of programmed death-ligand 1 expression levels in non-small cell lung cancer patients based on 18 F-fluorodeoxyglucose PET/computed tomography radiomics features.
  • 1 Jun 2026
  • Nuclear medicine communications
Impact of acquisition timing and background uptake on [131I]meta-iodobenzylguanidine SPECT/CT interpretation in pheochromocytoma and adrenal adenoma: Erratum.
  • 1 Jun 2026
  • Nuclear medicine communications
Breaking the shackles of morphology: a novel perspective on immunotherapy evaluation for nasopharyngeal carcinoma using multimodal imaging and radiomics - a review.
  • 1 Jun 2026
  • Nuclear medicine communications
Predicting persistent/recurrent cervical lymph node metastasis in papillary thyroid carcinoma with PET/CT-based multimodal radiomics: an image-pathology matching study.
  • 1 Jun 2026
  • Nuclear medicine communications

FAQs on Nuclear Medicine Communications